The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Species
Location
Reference
Gnus
(Connochaetes albojubatus)
Unspecified
Rankin, 1958b
Zebu cattle
(Bos indicus)
Unspecified
Katic, 1961
Wild rabbits
Scotland
Grieg et al., 1999; Beard et al., 2001b
Monogastric animals
Mules
Global
Eveleth and Gifford, 1943
Hogs
Global
Larsen et al., 1971
Chickens
Global
Larsen et al, 1981
Monkeys
Global
Chiodini et al., 1984
Pygmy asses
Global
Van Ulsen, 1970
Mandrills
(Papio sphinx)
Unspecified
Zwick et al., 2002
Horses
Global
Larsen et al., 1972
SOURCE: Adapted from Chiodini et al., 1984.
SPECTRUM OF DISEASE IN DOMESTICATED ANIMALS
Cattle
JD is characterized by vague and often variable clinical signs, and the clinical signs and the severity of gross and histological lesions do not always correspond (Allen et al., 1968; Downham, 1950; Hallman and Witter, 1933; Macindoe, 1950; Smyth, 1935; Smyth and Christie, 1950). Whitlock and Buergelt (1996) have described the following progression of disease in cattle (summarized in Table 2–2).
Stage I:Silent Infection
In Stage I, animals typically exhibit no overt evidence of infection with Mycobacterium avium subsp. paratuberculosis (Map). Stage I JD is typically found in calves and heifers, most immature young stock, and many adult cattle. No routine or special clinicopathologic tests or serology will detect disease in these animals. Only postmortum tissue culture or, less often, histopathology can detect infection at this early stage of disease.
Stage II:Subclinical Disease
Most animals in Stage II JD are adults that are carriers of Map. The animals do not exhibit clinical signs typical of JD, but they sometimes have detectable antibodies or exhibit altered cellular immune responses. Many are fecal-culture negative, although they intermittently shed low numbers of organisms in feces. In a small percentage (15–25 percent), disease can be detected by fecal culture, by altered cellular immune response, by serum antibodies, or by histopathology. An unknown proportion of Stage II animals progress slowly to Stage III (clinical disease), but because so many are culled